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Abstract
Background: Low levels of physical activity may increase the risk of developing metabolic syndrome, a cluster of
metabolic factors that are associated with the risk of premature death. It has been suggested that physical activity
may reduce the impact of factors associated with metabolic syndrome, but it is not known whether physical
activity may reduce mortality in people with metabolic syndrome.
Methods: In a prospective study of 50,339 people, 13,449 had metabolic syndrome at baseline and were followed up
for ten years to assess cause-specific mortality. The population was divided into two age groups: those younger than 65
years of age and those older than age 65. Information on their physical activity levels was collected at baseline.
Results: Metabolic syndrome was associated with higher mortality from all causes (hazard ratio (HR) 1.35, 95%
confidence interval (95% CI) 1.20 to 1.52) and from cardiovascular causes (HR 1.78, 95% CI 1.39 to 2.29) in people
younger than 65 years old than among other populations. In older people, there was no overall association of
metabolic syndrome with mortality. People with metabolic syndrome who reported high levels of physical activity at
baseline were at a reduced risk of death from all causes compared to those who reported no physical activity, both
in the younger age group (HR 0.52, 95% CI 0.37 to 0.73) and in the older age group (HR 0.59, 95% CI 0.47 to 0.74).
Conclusion: Among people with metabolic syndrome, physical activity was associated with reduced mortality from
all causes and from cardiovascular causes. Compared to inactivity, even low levels of physical activity were
associated with reduced mortality.
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Background
Metabolic syndrome, a clustering of metabolic risk factors,
increases the risk of premature death from cardiovascular
disease (CVD) threefold compared to people without
metabolic syndrome [1]. In the Western world, approxi-
mately 25% of people in the 40- to 49-year-old age group
and approximately 45% in the 60- to 69-year-old age
group may have metabolic syndrome, but its prevalence
appears to differ between populations and is dependent on
age, gender and ethnicity [2,3].
There is no single medication available to treat meta-
bolic syndrome, and each clustering factor needs to be
treated separately [4]. Lifestyle changes are highly recom-
mended as part of the treatment strategy [5,6]. The results
of population-based studies have suggested that a low
level of physical activity is associated with a high preva-
lence of metabolic syndrome [7-10], and clinical studies
have shown that exercise training may improve the risk
factor profile for people with established metabolic syn-
drome [11-13]. According to current recommendations,
people should engage in 30 minutes of moderately intense
activity five days per week or vigorous aerobic physical
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to promote and maintain good health [14,15]. Alterna-
tively, people can engage in a combination of moderate
and vigorous activity to meet the recommended guide-
lines. In addition, activities that maintain or increase mus-
cular strength and endurance are recommended for a
minimum of two days each week. It is not known whether
people with metabolic syndrome will benefit from a simi-
lar level of physical activity, and it is also not known
whether physical activity may reduce mortality in people
with metabolic syndrome.
In a prospective study of more than 13,000 men and
women with metabolic syndrome, we assessed whether
self-reported levels of physical activity are associated
with the risk of death from all causes and specifically
with the risk of death from cardiovascular causes.
Methods
Study population
An adult population ages 20 years and older in Nord-
Trøndelag County in Norway was invited to participate in
a large health survey (the Nord-Trøndelag Health Study 2,
or HUNT 2) from 1995 to 1997. Of 92,205 individuals,
65,215 (70.7%) accepted the invitation to enter the study
and underwent a medical examination that has been
described in detail elsewhere [16]. Briefly, the participants
filled in self-administered questionnaires and were sub-
jected to physical measurements, including anthropo-
metric factors and blood pressure, and a blood sample was
taken from all participants. Among many health-related
items, the questionnaire covered physical activity, smoking
habits, alcohol consumption, marital status, occupation
and educational attainment.
Exclusion criteria
On the basis of self-reports, we initially excluded 5,220
participants from mortality follow-up if they had a history
of stroke or myocardial infarction or known angina pec-
toris. Important information regarding physical activity
was missing for 9,656 people, and these initial participants
were also excluded. Therefore, the present study included
50,339 participants (13,449 with metabolic syndrome and
36,890 without metabolic syndrome) who were followed
up for cause-specific mortality.
End points and follow-up
Compulsory reporting of deaths by public health officers
and physicians is the basis for the Causes of Death Regis-
try in Norway, including coding of underlying causes of
death. End points in this study were deaths from any
cause and deaths from cardiovascular causes (Interna-
tional Classification of Disease (ICD)-9:390 to 9:459;
ICD-10:I00 to 10:I 99).
Serum glucose levels
Since blood samples were drawn throughout the day and
fasting samples could not be obtained, the time since the
most recent meal was carefully recorded. In the analyses,
it was adjusted for the time since the most recent meal to
compensate for the nonfasting state of the participants. A
total of 10,420 individuals (16%) reported that at least four
hours had passed since their most recent meal, and their
glucose levels were used as one factor in the identification
of people with prevalent metabolic syndrome.
Metabolic syndrome
Metabolic syndrome was defined as the concurrent preva-
lence of any three of the following five factors [17]: waist
circumference ≥94 cm for men and ≥80 cm for women,
serum triglyceride level ≥1.7 mmol/L, high-density lipo-
p r o t e i n<1 . 0m m o l / Li nm ales and < 1.3 mmol/L in
females, systolic blood pressure ≥130 mmHg or diastolic
blood pressure ≥85 mm Hg or treatment for hypertension,
fasting plasma glucose level ≥5.6 mmol/L, or previously
diagnosed or known type 2 diabetes.
Physical activity
The participants were asked about their physical activity
(PA) during leisure time. The PA questions differentiated
between light and hard physical activity during an ordin-
ary week, with four response options for each intensity
level (none, less than one hour, one to two hours or at
least three hours). The questions about hard and light PA
w e r en o tm u t u a l l ye x c l u s i v e ,a n dt h ed a t aa l l o w e du st o
construct a PA variable that roughly corresponded to the
current recommendations for aerobic physical activity
[14]. Moderate intensity PA has previously been
described as being equivalent to brisk walking [14], and
we therefore assumed that this response would corre-
s p o n dt ow h a tp e o p l er e p o r t e da sl i g h tP A .I nt h ec o n -
structed PA variable, duration of exercise was divided
into light PA (less than one hour and at least three hours
of light activity) and hard PA (less than one hour and at
least one hour of hard activity). Furthermore, we com-
bined hard and light PA into the following four activity
categories: Inactive (inactive regarding both light and
hard PA), Low (less than three hours of light PA and no
hard PA), Moderate (less than three hours of light PA
and less than one hour of hard PA or at least three hours
of light PA and no hard PA) and High (at least three
hours of light PA and less than one hour of hard PA, at
least three hours of light PA and at least one hour of
high PA, or less than three hours of light PA and at least
one hour of hard PA). Thus, low PA included both those
who reported less than one hour of light PA per week
and those who reported up to two hours of light PA per
week. Low PA indicated a PA level lower than what is
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with the current PA recommendations as it included
three hours or more of light PA or less than three hours
of light PA and less than one hour of hard PA (including
moderate and/or vigorous PA). High PA indicated an
activity level higher than the minimum recommended
level.
Statistical analysis
Person-years were calculated from the date of entrance
into the study until the date of death or until the end of
follow-up, 31 December 2007, whichever occurred first.
Cox regression analyses were used to compute hazard
ratios (HRs) of all-cause and cardiovascular mortality,
where the rate of death of people with metabolic syndrome
was compared with the mortality rate in people without
metabolic syndrome. The precision of the estimates was
assessed on the basis of 95% confidence intervals (95% CI).
In similar analyses, we estimated the association of PA
with the risk of death among people with metabolic syn-
drome using inactive participants as the reference category.
All estimated associations were adjusted for age by includ-
ing current age as the time scale in the Cox regression
model. In additional multivariable models, we adjusted for
the potential confounding effects of sex, marital status
(married, unmarried, divorced or separated and widow or
widower), education level attained (≤1 0y e a r s ,1 1t o1 4
years, ≥15 years or unknown), alcohol consumption (fre-
quency during the past two weeks: none, one to four, at
least five, total abstainer or unknown), smoking status
(never, former, current or unknown) and occupational
activity (mostly sedentary, much walking, much walking
and lifting, heavy physical work or unknown).
In a separate analysis, we examined the combined effect
of PA and metabolic syndrome status on the risk of death
from all causes and specifically from CVD. For this pur-
pose, participants who were without metabolic syndrome
and reported high PA served as the reference group.
Departure from the proportional hazards assumption was
evaluated by Schoenfeld residuals, and, in the analysis, we
found no evidence of departure. Potential effect modifica-
tion was assessed for age at baseline and sex. P values for
interaction were calculated by using likelihood ratio tests
to compare models with and without the interaction
terms. P values for linear trends were calculated by using
PA categories as an ordinal variable in the Cox regression
model. All statistical tests were two-sided, and the statisti-
cal analyses were conducted using Stata for Windows ver-
sion 10.0 software (StataCorp LP, Texas 77845, USA).
Ethics
All participants in the HUNT 2 study provided their
written consent, and the Regional Committee for Medi-
cal Research Ethics approved the study.
Results
Interaction
There was a significant interaction with age, but not with
sex. Therefore, the study population was divided into two
age groups (ages < 65 years and ≥65 years), and data for
men and women were combined.
Baseline characteristics
Baseline characteristics of the populations are presented in
Table 1. The total prevalence of metabolic syndrome was
27%. Its prevalence at baseline was 23% among partici-
pants younger than 65 years of age and 44% among parti-
cipants 65 years or older. In the younger age group, 53%
reported a level of exercise that was equal to or higher
than current recommendations, and only 9% reported that
t h e yw e r ei n a c t i v e( T a b l e1 ) .I nt h eo l d e ra g eg r o u p ,t h e
corresponding proportions were 41% and 19% (Table 1).
Metabolic syndrome and mortality
During a mean follow-up period of 10 years (standard
deviation ± 2 years), 1,839 persons among 13,449 with
metabolic syndrome died. In the group younger than 65
years of age, 26% of the deaths were caused by CVD, and
among people age 65 years or older, 43% of the deaths
were caused by CVD.
Among people younger than 65 years of age, those with
metabolic syndrome were at higher risk of death from all
causes (HR 1.35, 95% CI 1.20 to 1.52) and from CVD (HR
1.78, 95% CI 1.39 to 2.29) compared to people without
metabolic syndrome. In the older age group, there was no
clear association of metabolic syndrome with the risk of
dying (Figure 1).
Physical activity and mortality
Table 2 shows the relative risk of dying from all causes
and from CVD among people with metabolic syndrome.
The table shows that after adjustment for potentially con-
founding factors, the risk of death from all causes was
reduced with increasing PA level (P trend < 0.001).
Highly active people younger than 65 years of age had a
strong risk reduction in all-cause mortality (HR 0.52, 95%
CI 0.37 to 0.73) compared to inactive people. In the older
age group (≥65 years), the corresponding comparison
showed a similar risk reduction (HR 0.59, 95% CI 0.47 to
0.74).
The results related to deaths from CVD were similar to
those for all-cause mortality. Thus, the reduction in the
risk of dying from CVD related to increasing PA level
showed a linear trend (P trend = 0.02 for people < 65
years of age and P <0 . 0 0 1f o rp e o p l e≥65 years of age),
and the HRs for highly active people was 0.60 (95% CI:
0.29 to 1.22) for people younger than 65 years old and
0.52 (95% CI: 0.37 to 0.73) for people age 65 years or
older.
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We also assessed the combined effects of PA and
metabolic syndrome in the total population younger
than 65 years of age (Table 3). Our data showed that
the association between PA and mortality displayed
the same pattern in people with and without metabolic
syndrome. Interestingly, people with metabolic syn-
drome who reported high levels of PA had only a
slightly higher mortality risk compared to their healthy
counterparts (adjusted HR: 1.13, 95% CI: 0.87 to 1.49).
In older people with metabolic syndrome, the risk for
premature death was not significantly higher compared
to older people without metabolic syndrome. Thus, the
impact of PA was the same in people with and people
without metabolic syndrome ≥65 years old (data not
shown).
Discussion
In this large, prospective population study of men and
women with metabolic syndrome, we found a gradual
reduction in all-cause mortality associated with increas-
ing levels of PA. Importantly, the greatest mortality dif-
ference was found between people who reported no
activity and those who reported low levels of PA.
To our knowledge, this is the first study to evaluate
the association of PA with mortality among people with
metabolic syndrome. The main finding was in line with
prospective studies in the general population [18-21] in
showing that PA is associated with a reduction in mor-
tality from all causes, and specifically from CVD, among
people with metabolic syndrome. The substantial mor-
tality difference that we found between low levels of PA
and no activity also corresponds to findings in the gen-
eral population [21-23]. Less than 50% of adults in the
US meet the recommended level of PA [22], but our
results suggest that even PA at a level that most people
are able to achieve is likely to reduce mortality in people
with metabolic syndrome.
We cannot exclude the possibility that unknown factors
other than PA might explain the high mortality related to
physical inactivity. It is possible that being inactive reflects
prevalent illness and that therefore the stronger associa-
tion with mortality might be as expected. We attempted
to take this possibility into account by excluding partici-
pants with a history of stroke, myocardial infarction or
known angina pectoris.
We found no difference regarding risk in mortality
due to CVD between those who reported being inactive
Table 1 Descriptive statistics of people with metabolic syndrome in HUNT 2
a
Age group, years
Demographics <6 5 ≥65
Participants, n 9,883 3,566
Person-years, 124,466 50,269
Deaths (all causes), n 460 1,379
Deaths (CVD), n (% of all deaths) 119 (26) 592 (43)
Mean age at baseline, years (± SD) 45.8 (11.3) 73.1 (6.1)
Mean body mass index, kg/m
2 (± SD) 29.5 (4.0) 29.0 (3.9)
Mean waist circumference, cm (± SD) 95.3 (10.0) 95.1 (10.3)
Mean SBP, mmHg (± SD) 142.5 (17.3) 160.9 (22.3)
Mean DBP, mmHg (± SD) 85.1 (11.0) 87.7 (12.9)
Mean serum triglycerides, mmol/L (± SD) 2.8 (1.4) 2.6 (1.1)
Mean serum glucose, mmol/L (± SD) 5.6 (1.7) 6.3 (2.4)
Mean serum HDL, mmol/L (± SD) 1.1 (0.3) 1.2 (0.3)
Mean percentage of people taking diabetes medication (± SD) 3.8 (0.04) 12.6 (0.1)
Mean percentage of people taking BP medication (± SD) 11.5 (0.1) 33 (0.3)
Mean percentage of current smokers (± SD) 32.2 (0.3) 15.9 (0.1)
Mean percentage of sedentary occupational work (± SD) 28 (0.2) 45 (0.3)
Mean percentage of college or university education (± SD) 18 (0.2) 5 (0.05)
Participants’ PA levels
b,%
Inactive 91 9
Low 38 39
Moderate 27 29
High 26 12
aHUNT 2, Nord-Trøndelag Health Study 2; CVD, cardiovascular disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; PA,
physical activity; Inactive, no light and no hard physical activity; Low, less than three hours of light and no hard PA; Medium, less than three hours light and less
than one hour hard PA, or at least three hours light PA and no hard PA; High, at least three hours light PA and less than one hour hard PA or at least three hours
light PA and at least one hour hard PA or less than three hours light PA and at least one hour hard PA;
bbecause of rounding, percentages may not total 100.
Stensvold et al. BMC Medicine 2011, 9:109
http://www.biomedcentral.com/1741-7015/9/109
Page 4 of 8and those who reported low levels of PA among people
with metabolic syndrome in the age group younger than
65 years of age. However, that analysis was based on a
small number of deaths, and thus the statistical power
required to detect any effect was modest.
A number of studies have shown that metabolic syn-
drome is associated with increased risk of death from all
causes, and specifically from CVD, compared to people
without metabolic syndrome [1,5]. In our study, there
was a positive association of metabolic syndrome with
all-cause and CVD mortality only among people younger
than 65 years of age. Our finding is in line with that of
Hildrum et al. [24], who reported higher all-cause mor-
tality associated with metabolic syndrome in middle-aged
people but not in older adults. A possible explanation for
our observation is that people with low tolerance for car-
diovascular risk factors die before they reach old age and
that the risk factors associated with metabolic syndrome
have less effect on survival in older individuals.
It has been shown that PA may improve the factors
that constitute metabolic syndrome [12,25,26]. There-
fore, beneficial effects on weight, blood pressure, serum
lipid levels and metabolism of carbohydrates may be
important for the lower mortality associated with PA
among people with metabolic syndrome. Also, improve-
ment in cardiac function, especially in relation to the
intensity of PA [27], is likely to play a role.
T h eq u e s t i o na b o u tl e i s u r et i m eP Ai nt h eH U N T2
questionnaire did not distinguish between strength and
aerobic exercise, and therefore we cannot attribute the
observed effects to a particular type of exercise. People
who report being inactive are likely to be inactive; how-
ever, PA in questionnaire-based data is typically overre-
ported [28]. In this study, misclassification caused by
overreporting of PA would place some people into a
higher PA category than their true activity level would
Table 2 Levels of physical activity in people with metabolic syndrome and HRs of all-cause and CVD-related deaths
a
All-cause mortality CVD-related deaths
PA index Number Person-years Deaths HR
b HR
c (95% CI) P trend Deaths HR
b HR
c (95% CI) P trend
< 65 years old 9,883
Inactive
c 9,357 70 1.0 1.0 (Ref.) 15 1.0 1.0 (reference value)
Low 41,723 203 0.62 0.71 (0.54 to 0.94) 61 0.87 1.03 (0.58 to 1.83)
Moderate 30,398 114 0.52 0.58 (0.43 to 0.79) 26 0.56 0.63 (0.33 to 1.20)
High 28,119 73 0.46 0.52 (0.37 to 0.73) 17 0.51 0.60 (0.29 to 1.22)
< 0.001 0.02
≥65 years old 3,566
Inactive
d 5,620 375 1.0 1.0 (Ref.) 171 1.0 1.0 (reference value)
Low 13,347 522 0.76 0.75 (0.65 to 0.86) 235 0.76 0.76 (0.62 to 0.93)
Moderate 10,157 361 0.70 0.65 (0.56 to 0.76) 140 0.61 0.58 (0.46 to 0.74)
High 4,293 121 0.69 0.59 (0.47 to 0.74) 46 0.59 0.52 (0.37 to 0.73)
< 0.001 < 0.001
aCVD, cardiovascular disease; PA, physical activity; HR, hazard ratio; CI, confidence interval;
badjusted for age (continuous);
cadjusted for age (continuous), sex
(men and women), marital status (married or unmarried, widow or widower, divorced or separated), education level attained (≤10 years, 11 to 14 years, ≥15
years and unknown), alcohol consumption (frequency during past two weeks: none, one to four, at least five, total abstainer and unknown), smoking status
(never, former, current or unknown), occupational activity (mostly sedentary, much walking, much walking and lifting or heavy physical work);
dinactive
participants served as the reference group.
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Figure 1 Hazard ratios of all-cause and cardiovascular disease-
related mortality among people with metabolic syndrome.
Adjusted for age (continuous), sex (men and women), smoking status
(never, former, current or unknown), physical activity index (High,
Medium, Low or Inactive), marital status (married or unmarried, widow
or widower, divorced or separated), education level attained (≤10
years, 11 to 14 years, ≥15 years or unknown), alcohol consumption
(frequency during past two weeks: none, one to four, at least five or
total abstainer) and occupational activity (mostly sedentary, much
walking, much walking and lifting, heavy physical work or unknown).
Squares and diamonds represent risk estimates, and bars represent
95% CI. People without metabolic syndrome (represented by coloured
diamonds and squares) served as the reference group.
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most likely underestimate the effect of PA in this study.
The use of nonfasting glucose values in our study could
have been a potential source of bias. Glucose level was
used as a diagnostic criterion for metabolic syndrome only
if the levels were elevated four hours postprandial. Thus,
there was a potential risk of placing some people with
metabolic syndrome into the category of people without
metabolic syndrome. However, in a subanalysis, glucose
was used as a criterion in all subjects regardless of the
time since their most recent meal, and the results were
essentially the same. Validation of the PA questionnaire in
the HUNT 2 study showed that the “light activity” ques-
tion was not adequately correlated with other measures of
PA, whereas the reliability of hard PA and occupational
activity was found to be satisfactory [29]. The validation
was conducted among 108 men ages 20 to 39 years, how-
ever, and therefore we cannot be certain that the results
can be generalized to the rest of our study population. In
this study, an attempt was made to classify self-reported
PA so that it would correspond to the currently recom-
mended guidelines for PA. However, the classification was
not exact, and caution should be taken when interpreting
these data. Also, some participants might have changed
their PA levels after data collection, and these changes
might also have influenced the results. However, such
changes most likely would have underestimated the differ-
ences in mortality between the inactive group and the
groups with different activity levels.
Conclusion
In summary, we found that PA among people with
metabolic syndrome was associated with reduced risk of
death from all causes and from CVD. The reduction dis-
played a dose-risk association, but maybe equally impor-
tantly, we found that even a low level of PA was
associated with a substantial mortality reduction com-
pared to those who reported that they were physically
inactive. Our results strongly indicate that PA should be
recommended to people with metabolic syndrome to
reduce their risk of premature death.
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